Cancer mortality amongst people with epilepsy: A study of two cohorts with severe and presumed milder epilepsy

Epilepsy Research

Volumn 83, Issue 2-3, 2009, Pages 190-197

  Singh, Gagandeep ^a   Fletcher, Olivia ^b   Bell, Gail S ^c   McLean, Andre E ^d   Sander, Josemir W ^c,e  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Antiepileptic drugs; Cancer; Epilepsy; Standardised mortality ratio (SMR)

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; BLADDER CANCER; BONE CANCER; BRAIN TUMOR; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE SEVERITY; EPILEPSY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HODGKIN DISEASE; HUMAN; INTRAHEPATIC BILE DUCT; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; PLEURA CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SMALL INTESTINE CANCER; SOFT TISSUE CANCER; STANDARDIZED MORTALITY RATIO; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; COHORT STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 58849088822     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.11.001     Document Type: Article

References (20)

1. Adelöw C., Ahlbom A., Feychting M., Johnsson F., Schwartzbaum J., and Tomson T. Epilepsy as a risk factor for cancer. J. Neurol. Neurosurg. Psychiatry 77 (2006) 784-786
2. Clemmesen J., and Hjalgrim-Jensen S. Is phenobarbital carcinogenic? A follow-up of 8078 epileptics. Ecotoxicol. Environ. Saf. 1 (1978) 457-470
3. Clemmesen J., and Hjalgrim-Jensen S. Does phenobarbital cause intracranial tumors? A follow-up through 35 years. Ecotoxicol. Environ. Saf. 5 (1981) 255-260
4. Day S.M., Wu Y.W., Strauss D.J., Shavelle R.M., and Reynolds R.J. Causes of death in remote symptomatic epilepsy. Neurology 65 (2005) 216-222
5. Driver H.E., and McLean A.E. Dose-response relationship for phenobarbitone promotion of liver tumors initiated by single dose dimethylnitrosomine. Br. J. Exp. Pathol. 67 (1986) 131-139
6. Feinstein A.R. The pretherapeutic classification of comorbidity in chronic disease. J. Chronic Dis. 23 (1970) 455-468
7. Friedman G.D., and Ury H.K. Initial screening for carcinogenicity of commonly used drugs. J. Natl. Cancer Inst. 65 (1980) 723-733
8. Gaitatzis A., Carroll K., Majeed A., and Sander J.W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45 (2004) 1613-1622
9. Hyman G.A., and Sommers S.C. The development of Hodgkin's disease and lymphoma during anticonvulsant therapy. Blood 28 (1966) 416-427
10. Kruger G. Effect of dilantin in mice I. Changes in the lymphoreticular tissue after acute exposure. Virchows Arch. A Pathol. Pathol. Anat. 349 (1970) 297-311
11. Lamminpaa A., Pukkala E., Teppo L., and Neuvonen P.J. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur. J. Clin. Pharmacol. 58 (2002) 137-141
12. McLean A.E., and Marshall A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. Br. J. Exp. Pathol. 52 (1971) 323-329
13. Olsen J.H., Boice Jr. J.D., Jensen J.P., and Fraumeni Jr. J.F. Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81 (1989) 803-809
14. Olsen J.H., Schulgen G., Boice J.D., Whysner J., Travis L.B., Williams G.M., Johnson F.B., and McGee J.O. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res. 55 (1995) 294-297
15. Peraino C., Fry R.J.M., and Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31 (1971) 1506-1512
16. Selby J.V., Friedman G.D., and Fireman B.H. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res. 49 (1989) 5736-5747
17. Shirts S.B., Annegers J.F., Hauser W.A., and Kurland L.T. Cancer incidence in a cohort of patients with seizure disorders. J. Natl. Cancer Inst. 77 (1986) 83-87
18. Singh G., Driever P.H., and Sander J.W. Cancer risk in people with epilepsy: the role of antiepileptic drugs. Brain 128 (2005) 7-17
19. Smith G.D., Shipley M.J., and Rose G. Magnitude and causes of socio-economic differentials in mortality: further evidence from the Whitehall Study. J. Epidemiol. Commun. Health 44 (1990) 265-270
20. White S.J., McLean A.E., and Howland C. Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet 2 (1979) 458-461